Mean vision gains of +9 letters among patients with extensive coverage of OpRegen cell therapy to the Geographic Atrophy (GA) lesion site Evidence of retinal structural improvement persisted out to 3 years Anatomical and functional improvements occur following a single administration of OpRegen cell therapy CARLSBAD, Calif. / Jun 23, 2025 / Business Wire / Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a... Read More